NYSE:RCUS   Arcus Biosciences, Inc.
Analyst targets are pretty high and carries Zacs #1 rating. A breakout will lead it higher.
finance.yahoo.c...te/RCUS/holders?p=RCUS

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.